|
|||||
|
|

IT solutions provider CDW (NASDAQGS:CDW) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.2% year on year to $5.98 billion. Its non-GAAP profit of $2.60 per share was 4.4% above analysts’ consensus estimates.
Is now the time to buy CDW? Find out in our full research report (it’s free).
CDW’s second quarter results reflected positive sales momentum and exceeded Wall Street revenue and profit expectations, yet the market reacted negatively. Management attributed the quarter’s growth to strong demand for hardware upgrades, particularly client devices, and infrastructure projects, bolstered by the Windows 10 end-of-life cycle. CEO Christine Leahy highlighted that commercial and healthcare channels were standouts, with corporate net sales up 18% and healthcare up 24%, offsetting declines in education and federal government segments. Leahy noted, “Our balanced portfolio of diverse customer end markets, breadth of offerings, and disciplined execution enabled us to capture opportunities despite persistent funding shifts and policy headwinds, particularly in education.”
Looking ahead, CDW’s outlook is shaped by ongoing caution in public sector markets and continued investments in its services and AI capabilities. Management expects government and education headwinds to persist, with state and local funding instability and changing protocols impacting demand. CFO Al Miralles emphasized that the company is maintaining a prudent approach, stating, “We are holding our full year 2025 view of low single-digit growth for the IT market” and remain focused on expense discipline and capital allocation. Leahy added that CDW’s strategy is to leverage its full-stack solutions, especially in consulting and managed services, to help customers navigate complexity and accelerate adoption of AI and digital transformation initiatives.
Management credited the quarter’s performance to robust hardware refresh cycles, strong execution in commercial and healthcare segments, and increased customer focus on mission-critical projects, while acknowledging public sector softness and changing customer funding dynamics.
CDW expects continued macro uncertainty and public sector funding volatility to shape near-term growth, while investments in services, AI, and customer-centric solutions remain central to its strategy.
In future quarters, the StockStory team will monitor (1) the pace of recovery in public sector markets, especially as funding protocols and stimulus transitions play out; (2) customer adoption of new AI and managed services offerings, gauging their impact on revenue mix and margins; and (3) the balance between hardware refresh demand and potential macroeconomic slowdowns. Execution on service expansion and resilience in commercial and healthcare channels will also be critical to watch.
CDW currently trades at $160.15, down from $165.14 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Nov-07 | |
| Nov-06 | |
| Nov-06 | |
| Nov-05 | |
| Nov-05 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-04 | |
| Nov-02 | |
| Oct-28 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite